These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38597219)

  • 1. Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials.
    Bedward A; Kaur J; Seedat S; Donohue H; Kow CS; Rasheed MK; Javed A; Hasan SS
    Expert Rev Neurother; 2024 May; 24(5):527-539. PubMed ID: 38597219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.
    McGowan NM; Kim DS; de Andres Crespo M; Bisdounis L; Kyle SD; Saunders KEA
    CNS Drugs; 2022 Apr; 36(4):345-363. PubMed ID: 35305257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
    De Crescenzo F; D'Alò GL; Ostinelli EG; Ciabattini M; Di Franco V; Watanabe N; Kurtulmus A; Tomlinson A; Mitrova Z; Foti F; Del Giovane C; Quested DJ; Cowen PJ; Barbui C; Amato L; Efthimiou O; Cipriani A
    Lancet; 2022 Jul; 400(10347):170-184. PubMed ID: 35843245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
    Liira J; Verbeek JH; Costa G; Driscoll TR; Sallinen M; Isotalo LK; Ruotsalainen JH
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009776. PubMed ID: 25113164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.
    Zhang W; Chen XY; Su SW; Jia QZ; Ding T; Zhu ZN; Zhang T
    Neurol Sci; 2016 Jan; 37(1):57-65. PubMed ID: 26255301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eszopiclone for insomnia.
    Rösner S; Englbrecht C; Wehrle R; Hajak G; Soyka M
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010703. PubMed ID: 30303519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z-drug for schizophrenia: A systematic review and meta-analysis.
    Kishi T; Inada K; Matsui Y; Iwata N
    Psychiatry Res; 2017 Oct; 256():365-370. PubMed ID: 28686934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L; Huang Y; Xu R; Wei Y; Xiao L; Wang G
    Sleep Med; 2019 Oct; 62():6-13. PubMed ID: 31518944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease.
    Wang YY; Zheng W; Ng CH; Ungvari GS; Wei W; Xiang YT
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):50-57. PubMed ID: 27645169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer's disease and sleep disorder: A randomized controlled trial.
    Huo S; Cheng L; Li S; Xu F
    Brain Behav; 2022 Feb; 12(2):e2488. PubMed ID: 35041261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Gao F; Liu T; Tuo M; Chi S
    Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    Beuckmann CT; Suzuki H; Musiek ES; Ueno T; Sato T; Bando M; Osada Y; Moline M
    J Alzheimers Dis; 2021; 81(3):1151-1167. PubMed ID: 33843668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.
    Buscemi N; Vandermeer B; Hooton N; Pandya R; Tjosvold L; Hartling L; Baker G; Klassen TP; Vohra S
    J Gen Intern Med; 2005 Dec; 20(12):1151-8. PubMed ID: 16423108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
    Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review.
    Beresford B; McDaid C; Parker A; Scantlebury A; Spiers G; Fairhurst C; Hewitt C; Wright K; Dawson V; Elphick H; Thomas M
    Health Technol Assess; 2018 Oct; 22(60):1-296. PubMed ID: 30382936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options in the management of sleep disorders in visually impaired children: a systematic review.
    Khan SA; Heussler H; McGuire T; Dakin C; Pache D; Norris R; Cooper D; Charles B
    Clin Ther; 2011 Feb; 33(2):168-81. PubMed ID: 21497703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage travel fatigue and jet lag in athletes? A systematic review of interventions.
    Janse van Rensburg DCC; Jansen van Rensburg A; Fowler P; Fullagar H; Stevens D; Halson S; Bender A; Vincent G; Claassen-Smithers A; Dunican I; Roach GD; Sargent C; Lastella M; Cronje T
    Br J Sports Med; 2020 Aug; 54(16):960-968. PubMed ID: 32303523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.